Israel
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 405.00 M
|
Dec. 31, 2023 | USD 20.86 | -2.64% |
|
Israel |
|
2 |
USD 24.32 M
|
Dec. 31, 2023 | USD 5.51 | -1.08% |
|
Israel |
|
3 |
USD 19.63 M
|
Dec. 31, 2023 | USD 20.06 | -0.66% |
|
Israel |
|
4 |
USD 17.25 M
|
Dec. 31, 2023 | USD 6.13 | 0.95% |
|
Israel |
|
5 |
USD 10.06 M
|
Dec. 31, 2023 | USD 7.30 | -3.84% |
|
Israel |
|
6 |
USD 6.08 M
|
Dec. 31, 2023 | USD 1.20 | 0.92% |
|
Israel |
|
7 |
USD 4.75 M
|
Dec. 31, 2023 | USD 2.04 | NA |
|
Israel |
|
8 |
USD 4.02 M
|
Dec. 31, 2023 | USD 0.52 | -0.27% |
|
Israel |
|
9 |
USD 800.34 K
|
Dec. 31, 2023 | USD 3.80 | 0.26% |
|
Israel |
|
10 |
USD 305.15 K
|
Dec. 31, 2023 | USD 0.08 | 0.04% |
|
Israel |
|
11 |
USD -4.64 K
|
Dec. 31, 2023 | USD 0.00 | -99.04% |
|
Israel |
|
12 |
USD -60.87 K
|
Dec. 31, 2023 | USD 0.19 | 1.64% |
|
Israel |
|
13 |
USD -523.59 K
|
Dec. 31, 2023 | USD 0.54 | -5.79% |
|
Israel |
|
14 |
USD -651.34 K
|
Dec. 31, 2023 | USD 0.84 | 0.91% |
|
Israel |
|
15 |
USD -688.25 K
|
Dec. 31, 2023 | USD 0.73 | -4.24% |
|
Israel |
|
16 |
USD -765.00 K
|
Dec. 31, 2023 | USD 0.02 | 1.63% |
|
Israel |
|
17 |
USD -1.14 M
|
Dec. 31, 2023 | USD 0.20 | -2.14% |
|
Israel |
|
18 |
USD -1.18 M
|
Dec. 31, 2023 | USD 0.51 | -4.99% |
|
Israel |
|
19 |
USD -1.45 M
|
Dec. 31, 2023 | USD 0.19 | 2.52% |
|
Israel |
|
20 |
USD -1.55 M
|
Dec. 31, 2023 | USD 2.58 | -3.90% |
|
Israel |
|
21 |
USD -1.82 M
|
Dec. 31, 2023 | USD 0.19 | -0.67% |
|
Israel |
|
22 |
USD -1.93 M
|
Dec. 31, 2023 | USD 1.21 | 0.04% |
|
Israel |
|
23 |
USD -2.99 M
|
Dec. 31, 2023 | USD 0.09 | -4.99% |
|
Israel |
|
24 |
USD -3.04 M
|
Dec. 31, 2023 | USD 4.33 | 4.29% |
|
Israel |
|
25 |
USD -3.09 M
|
Dec. 31, 2023 | USD 0.20 | 2.02% |
|
Israel |
|
26 |
USD -3.90 M
|
Dec. 31, 2023 | USD 4.83 | -0.52% |
|
Israel |
|
27 |
USD -4.36 M
|
Dec. 31, 2023 | USD 0.51 | 17.58% |
|
Israel |
|
28 |
USD -4.37 M
|
Dec. 31, 2023 | USD 2.26 | -2.59% |
|
Israel |
|
29 |
USD -4.67 M
|
Dec. 31, 2023 | USD 2.73 | -8.00% |
|
Israel |
|
30 |
USD -5.16 M
|
Dec. 31, 2023 | USD 0.87 | 0.07% |
|
Israel |
|
31 |
USD -5.18 M
|
Dec. 31, 2023 | USD 0.07 | 0.45% |
|
Israel |
|
32 |
USD -6.20 M
|
Dec. 31, 2023 | USD 19.02 | 3.99% |
|
Israel |
|
33 |
USD -6.90 M
|
Dec. 31, 2023 | USD 2.82 | -2.08% |
|
Israel |
|
34 |
USD -7.51 M
|
Dec. 31, 2023 | USD 3.84 | -2.29% |
|
Israel |
|
35 |
USD -8.12 M
|
Dec. 31, 2023 | USD 4.46 | 11.46% |
|
Israel |
|
36 |
USD -8.20 M
|
Dec. 31, 2023 | USD 0.01 | 0.04% |
|
Israel |
|
37 |
USD -8.20 M
|
Dec. 31, 2023 | USD 0.04 | -0.60% |
|
Israel |
|
38 |
USD -8.86 M
|
Dec. 31, 2023 | USD 2.36 | -1.67% |
|
Israel |
|
39 |
USD -9.58 M
|
Dec. 31, 2023 | USD 2.74 | -3.52% |
|
Israel |
|
40 |
USD -9.71 M
|
Dec. 31, 2023 | USD 3.44 | 0.58% |
|
Israel |
|
41 |
USD -10.04 M
|
Dec. 31, 2023 | USD 0.09 | -0.28% |
|
Israel |
|
42 |
USD -10.21 M
|
Dec. 31, 2023 | USD 1.65 | -1.71% |
|
Israel |
|
43 |
USD -10.73 M
|
Dec. 31, 2023 | USD 1.03 | -0.96% |
|
Israel |
|
44 |
USD -12.99 M
|
Dec. 31, 2023 | USD 1.85 | 10.75% |
|
Israel |
|
45 |
USD -14.14 M
|
Dec. 31, 2023 | USD 1.56 | -3.11% |
|
Israel |
|
46 |
USD -15.58 M
|
Dec. 31, 2023 | USD 1.24 | 5.08% |
|
Israel |
|
47 |
USD -20.48 M
|
June 30, 2024 | USD 4.33 | -2.68% |
|
Israel |
|
48 |
USD -21.14 M
|
Dec. 31, 2023 | USD 2.67 | 0.76% |
|
Israel |
|
49 |
USD -22.09 M
|
Dec. 31, 2023 | USD 3.09 | 5.46% |
|
Israel |
|
50 |
USD -22.27 M
|
Dec. 31, 2023 | USD 0.02 | -1.36% |
|
Israel |
The Health Care company in Israel with the highest EBIT is Teva Pharmaceutical Industries Limited (Tel Aviv Stock Exchange: TEVA.TA) at USD 405.00 M.
The Health Care company in Israel with the lowest EBIT is Nano-X Imaging Ltd. (NasdaqGM: NNOX) at USD -59.50 M.
The top 10 Health Care companies in Israel by EBIT are Teva Pharmaceutical Industries Limited, RedHill Biopharma Ltd., Ilex Medical Ltd, Golden House Ltd, Kamada Ltd., Together Pharma Ltd, MIND C.T.I. Ltd, Novolog (Pharm-Up 1966) Ltd, Rekah Pharmaceutical Industry Ltd. and Bio-View Ltd.
The bottom 10 Health Care companies in Israel by EBIT are Nano-X Imaging Ltd., BioLineRx Ltd., Alpha Tau Medical Ltd., Evogene Ltd., Chemomab Therapeutics Ltd., Tikun Olam-Cannbit Pharmaceuticals Ltd, Enlivex Therapeutics Ltd., Purple Biotech Ltd., PolyPid Ltd. and InspireMD, Inc..